Electroconvulsive therapy (ECT) increases GMV, particularly in the hippocampal region, enhances BDNF and VEGF expression, and lowers circulating cytokines in patients with depression [92,93,94]. The gene discussed is VEGFA; the disease is depressive symptom measurement.